Below is a comprehensive archive of press releases from MSF USA. Use the options in the boxes below to filter results based on your preferences.

Topic

July 23, 2015

VANCOUVER—At the International AIDS Society (IAS) Conference today, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) warned that middle-income countries (MICs), which will be home to 70 percent of people living with HIV by 2020, face increasing threats to their ability to access affordable generic medicines, which are crucial to countries’ ability to reach the global UNAIDS 90/90/90* targets.

July 21, 2015

New MSF report surveying lay counselor policies across eight countries highlights major weaknesses for adherence support

July 20, 2015

Vancouver, July 20, 2015—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières Borders (MSF) applauded the results of the Strategic Timing of Antiretroviral Treatment (START) trial, released today at the International AIDS Society Conference (IAS) in Vancouver, showing that immediate treatment is beneficial for individuals regardless of the status of their immune system.

May 09, 2015

MONROVIA, LIBERIA/BRUSSELS—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the World Health Organization's declaration that Liberia is Ebola-free after 42 days with no recorded cases, while warning that the outbreak is not over, as new cases continue in neighboring Guinea and Sierra Leone.

Cross-border surveillance must be improved to prevent Ebola from re-emerging in Liberia, MSF said.

March 20, 2015

MSF releases a critical analysis of the global Ebola response one year into the deadliest outbreak in history.

February 25, 2015

SEATTLE/NEW YORK—Among individuals not receiving antiretroviral treatment, men had twice the level of HIV virus in their blood as women at the same stage in the disease, according to one of the major findings of a three-country Doctors Without Borders/Médecins Sans Frontières (MSF) population survey presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle Wednesday.

February 24, 2015

Initial results of a clinical trial of the experimental drug favipiravir suggest that it can reduce mortality among patients with low levels of the Ebola virus in their blood, but is ineffective for patients with high viral loads who are very sick with the disease.

February 04, 2015

BRUSSELS/NEW YORKA trial of the experimental Ebola drug brincidofovir in Liberia has officially ended due to a significant drop in the number of new Ebola cases and the drug manufacturer’s decision to withdraw from the trial, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières said Tuesday. 

December 10, 2014

1.5 million people in Freetown and surrounding area to receive medicines.

December 03, 2014

NEW YORK—A United States government program meant to reward pharmaceutical companies for investing in research and development (R&D) for neglected diseases, and which will soon include Ebola on its list of eligible diseases, is enriching drug companies without ensuring that patients, treatment providers, or governments have access to these lifesaving drugs at an affordable price, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) Monday.

Pages